Literature DB >> 8814721

Evaluation of lung clearance of inhaled pertechnegas.

S Fanti1, G Compagnone, D Pancaldi, R Franchi, C Corbelli, M Marengo, C Onofri, R Galassi, M Levorato, N Monetti.   

Abstract

Pertechnegas is a new ventilation agent produced by modifying the atmosphere of combustion of Technegas. Due to its rapid disappearance from the lungs, Pertechnegas has been suggested as useful in measuring pulmonary epithelial permeability. This study aimed to assess the reliability of ventilation scans with Pertechnegas to evaluate alveolar-capillary permeability. Six non-smokers with no evidence of pulmonary disease were investigated. Scintigraphic data were used to evaluate the site of Pertechnegas deposition (by assessing the Penetration Index [PI] of the gas), its clearance rate (by calculating the time to half-clearance [T1/2]) and its lung distribution (by means of a pixel-by-pixel analysis. PI measurements produced a mean value of 88.8 +/- 13.3% (range 69-117%). Time activity curves showed a fast clearance in all cases (mean T1/2 = 10.7 +/- 2.1 min, range 8.1-14.3 min). Comparison of statistical indices of uniform deposition (skewness and kurtosis) indicated satisfactory homogeneity of Pertechnegas distribution throughout the lungs. These data show that after inhalation Pertechnegas has a peripheral deposition and a homogeneous distribution in the lungs and is rapidly cleared through the alveolar-capillary barrier. In conclusion Pertechnegas can be recommended as a potential radiopharmaceutical for studying the pulmonary epithelial barrier.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8814721     DOI: 10.1007/bf03165070

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  18 in total

1.  [Pulmonary distribution of 99mTc-technegas--a comparative study of radioactive inert gases].

Authors:  K Kawakami; T Shimada; S Tominaga; Y Mori; E Goto; Y Hirasawa
Journal:  Nihon Kyobu Shikkan Gakkai Zasshi       Date:  1992-10

2.  Commentary. Clinical experience with technegas.

Authors:  I P Murray
Journal:  Clin Nucl Med       Date:  1991-04       Impact factor: 7.794

3.  Technegas and Pertechnegas particle size distribution.

Authors:  J J Lloyd; R A Shields; C J Taylor; R S Lawson; J M James; H J Testra
Journal:  Eur J Nucl Med       Date:  1995-05

4.  Technegas--a new ventilation agent for lung scanning.

Authors:  W M Burch; P J Sullivan; C J McLaren
Journal:  Nucl Med Commun       Date:  1986-12       Impact factor: 1.690

5.  The characterization of radioaerosol deposition in the healthy lung by histogram distribution analysis.

Authors:  C S Garrard; T R Gerrity; J F Schreiner; D B Yeates
Journal:  Chest       Date:  1981-12       Impact factor: 9.410

6.  Distribution of inhaled 99mtechnetium labelled ultrafine carbon particle aerosol (Technegas) in human lungs.

Authors:  T C Amis; A B Crawford; A Davison; L A Engel
Journal:  Eur Respir J       Date:  1990-06       Impact factor: 16.671

7.  Intrapulmonary distribution of 99mtechnetium labelled ultrafine carbon aerosol (Technegas) in severe airflow obstruction.

Authors:  A B Crawford; A Davison; T C Amis; L A Engel
Journal:  Eur Respir J       Date:  1990-06       Impact factor: 16.671

8.  Technetium-99m labeled micro aerosol "Pertechnegas". A new agent for ventilation imaging in suspected pulmonary emboli.

Authors:  W L Ashburn; E V Belezzuoli; W A Dillon; B D Mensh; D Hoogland; D W Yeung; G E Coade
Journal:  Clin Nucl Med       Date:  1993-12       Impact factor: 7.794

9.  An improved radionuclide technique for the detection of altered pulmonary permeability.

Authors:  P Monaghan; I Provan; C Murray; D W Mackey; H Van der Wall; B M Walker; P D Jones
Journal:  J Nucl Med       Date:  1991-10       Impact factor: 10.057

10.  Respiratory clearance of aerosolized radioactive solutes of varying molecular weight.

Authors:  G J Huchon; A B Montgomery; A Lipavsky; J M Hoeffel; J F Murray
Journal:  J Nucl Med       Date:  1987-05       Impact factor: 10.057

View more
  1 in total

Review 1.  Radiopharmaceutical Labelling for Lung Ventilation/Perfusion PET/CT Imaging: A Review of Production and Optimization Processes for Clinical Use.

Authors:  Frédérique Blanc-Béguin; Simon Hennebicq; Philippe Robin; Raphaël Tripier; Pierre-Yves Salaün; Pierre-Yves Le Roux
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.